| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/14/2007 | WO2007066109A1 Bispecific ligands with binding specificity to cell surface targets and methods of use therefor |
| 06/14/2007 | WO2007066081A1 Anti-inflammatory peptides |
| 06/14/2007 | WO2007066018A2 Novel peptides and the biological use thereof |
| 06/14/2007 | WO2007065812A1 Process for the preparation of ferri-succinylcasein |
| 06/14/2007 | WO2007065588A1 Pharmaceutical compositions comprising cyclosporin |
| 06/14/2007 | WO2007065482A1 Use of transferrins for treating destructive inflammation of mucous membrane |
| 06/14/2007 | WO2007065451A1 Means for preventing and treating rhinitis of different ethiology, method for the production thereof, a pharmaceutical composition based thereon and a preventing and treating method |
| 06/14/2007 | WO2007065450A1 Means for preventing and treating conjunctivitis of different ethiology (variants) and a method for the use thereof |
| 06/14/2007 | WO2007065437A2 Modulation of the p2y2 receptor pathway |
| 06/14/2007 | WO2007065421A1 Treatment of trichodynia and superficial temporal artery swelling |
| 06/14/2007 | WO2007065273A1 Mucopolysaccharidosis (mps) diagnostic methods, systems, kits and assays associated therewith |
| 06/14/2007 | WO2007065265A1 Cross-linking reagents for hemoglobin and hemoglobin products cross-linked therewith |
| 06/14/2007 | WO2007065226A1 Vip fragments and methods of use |
| 06/14/2007 | WO2007053455A3 Polypeptide ligans for toll-like receptor 4 (tlr4) |
| 06/14/2007 | WO2007048848A3 V-atpase inhibitors for use in the treatment of septic shock |
| 06/14/2007 | WO2007047504A3 Natriuretic peptide modified transferrin fusion proteins |
| 06/14/2007 | WO2007039788A8 Composition and methods for inhibiting h. pylori adhesion and infection |
| 06/14/2007 | WO2007038407A3 Compositions and methods for treating nervous system disorders |
| 06/14/2007 | WO2007034480A3 Heparanases and splice variants thereof, ponucleotides encoding them and uses thereof |
| 06/14/2007 | WO2007032013A3 Compounds for improving nutritional status, cognition and survival |
| 06/14/2007 | WO2007024921A3 Combination therapies for inhibiting integrin-extracellular matrix interactions |
| 06/14/2007 | WO2007024628A3 Ply-gbs mutant lysins |
| 06/14/2007 | WO2007022255A3 Pharmaceutical formulations for sustained release |
| 06/14/2007 | WO2007019411A3 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 06/14/2007 | WO2007017580A3 Globin-based implantable preparation |
| 06/14/2007 | WO2007015171A3 Method of treating patients with a mucinous glycoprotein (muc-1) vaccine |
| 06/14/2007 | WO2007014253A3 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 06/14/2007 | WO2006124699A3 Blockade of pin1 prevents cytokine production by activated immune cells |
| 06/14/2007 | WO2006120580A3 Modified interferon-gamma polypeptides and methods for using modified interferon-gamma polypeptides |
| 06/14/2007 | WO2006119183A3 Method for increasing cardiac mass and performance |
| 06/14/2007 | WO2006118966A3 Phospholipid formulations and uses thereof in lung disease detection and treatment |
| 06/14/2007 | WO2006113614A3 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells |
| 06/14/2007 | WO2006109192A3 Antifungal bifunctional molecules, methods of construction and methods of treating fungal infection therewith |
| 06/14/2007 | WO2006102659A3 CONJUGATES OF AN hGH MOIETY AND A POLYMER |
| 06/14/2007 | WO2006096473A3 Identification of polynucleotides for predicting activity of compunds that interact with and/or modulate protein tyrosine kinases and/or protein tyrosine kinase pathways in breast cells |
| 06/14/2007 | WO2006091505A3 Neuropeptide y receptor agonists |
| 06/14/2007 | WO2006078629A3 In-situ crosslinkable elastin-like polypeptides for defect filling in cartilaginous tissue repair |
| 06/14/2007 | WO2006073889A3 Sustained delivery of pdgf using self-assembling peptide nanofibers |
| 06/14/2007 | WO2006069181A3 Compositions and methods for promoting wound healing and tissue regeneration |
| 06/14/2007 | WO2006065377A3 Methods of treating lentivirus infection |
| 06/14/2007 | WO2006002262A3 Genes and pathways differentially expressed in bipolar disorder and/or major depressive disorder |
| 06/14/2007 | WO2004043335A3 Methods of treating infection by drug resistant bacteria |
| 06/14/2007 | WO2004032847A3 Hepatocyte growth factor variants |
| 06/14/2007 | US20070136896 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein |
| 06/14/2007 | US20070136829 Novel type-1 cytokine receptor glm-r |
| 06/14/2007 | US20070135625 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18 |
| 06/14/2007 | US20070135618 Peptide epitopes recognized by disease promoting cd4+ t lymphocytes |
| 06/14/2007 | US20070135418 Compositions and methods relating to novel compounds and targets thereof |
| 06/14/2007 | US20070135386 Novel Compounds and Compositions as Cathepsin Inhibitors |
| 06/14/2007 | US20070135381 Derivatives of branch-chain lipophilic molecular and uses thereof |
| 06/14/2007 | US20070135373 Method for selective expression of therapeutic genes by hyperthermia |
| 06/14/2007 | US20070135371 Antisense IAP nucleobase oligomers and uses thereof |
| 06/14/2007 | US20070135356 Gamma aminobutyric acid antagonist; naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative disorders; analgesics; drug withdrawal |
| 06/14/2007 | US20070135355 Functionalized diphenolics and absorbable polymers therefrom |
| 06/14/2007 | US20070135354 Hematopoietic stimulation |
| 06/14/2007 | US20070135353 Crystalline n-formyl hydroxylamine compounds |
| 06/14/2007 | US20070135352 Use of lh for generating libido and reaching orgasm in female subjects |
| 06/14/2007 | US20070135351 polymer conjugated drug; genetically engineered truncated analogs of significantly lower-molecular-weight and having equal or better potency, pharmacokinetic properties and pharmacological properties as existing Y2R agonists; also pegylated analogs; treating obesity; dietetics; metabolic disorders |
| 06/14/2007 | US20070135350 Methods of Identifying Compounds that Modulate IL-4 Receptor-Mediated IgE Synthesis Utilizing a B-Cell Associated Protein |
| 06/14/2007 | US20070135349 Method for increasing the serum half-life of a biologically active molecule |
| 06/14/2007 | US20070135348 Methods and compositions for the treatment of peripheral artery disease |
| 06/14/2007 | US20070135347 Heterodimeric soluble receptor for identifying modulators for prevention and treatment of cell proliferative disorders |
| 06/14/2007 | US20070135346 Prodrugs of CC-1065 analogs |
| 06/14/2007 | US20070135345 Use of GLP-2 for the treatment or prevention, of bone-related disorders |
| 06/14/2007 | US20070135344 Novel growth factor and a genetic sequence encoding same |
| 06/14/2007 | US20070135343 Sodium chloride solution for drug reconstitution or dilution |
| 06/14/2007 | US20070135342 Modified Factor VIII |
| 06/14/2007 | US20070135341 Use of CAP37 (cationic antimicrobial protein of Mr 37 kDa) peptides and pegylated derivatives to treat fungal infections |
| 06/14/2007 | US20070135340 IGF-1 novel peptides |
| 06/14/2007 | US20070135339 Bacteriocin inducer peptides |
| 06/14/2007 | US20070135338 Human GLP-1 mimetibodies, compositions, methods and uses |
| 06/14/2007 | US20070135337 Vaccine for the Prevention and Treatment of Alzheimer's and Amyloid Related Diseases |
| 06/14/2007 | US20070135336 Follistatin isoforms and uses thereof |
| 06/14/2007 | US20070135335 Therapeutic molecules |
| 06/14/2007 | US20070135334 Peptides and methods using same for diagnosing and treating amyloid-associated diseases |
| 06/14/2007 | US20070134764 Endogenous and non-endogenous version of human G protein-coupled receptors |
| 06/14/2007 | US20070134763 Anti-virus therapy for respiratory diseases |
| 06/14/2007 | US20070134745 Using cytokine receptor-16 expression as evaluative tool in diagnosis of cell proliferative disorders |
| 06/14/2007 | US20070134735 Transcriptional regulation of the human beta3-adrenergic receptor gene |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | US20070134720 Method of detecting effect of controlling synoviolin activity |
| 06/14/2007 | US20070134719 Method of controlling pharmacokinetics of immunomodulatory compounds |
| 06/14/2007 | US20070134718 Use of interleukin-15 |
| 06/14/2007 | US20070134693 Method for modulating the binding activity of a novel ICAM-3 binding receptor on sinusoidal endothelial cells in liver and lymph nodes |
| 06/14/2007 | US20070134680 Lipid metabolism molecules |
| 06/14/2007 | US20070134674 Method for the prognosis and/or diagnosis of a cancer |
| 06/14/2007 | US20070134664 Human autism susceptibility gene and uses thereof |
| 06/14/2007 | US20070134660 Methods for identifying modulators of kinesin activity |
| 06/14/2007 | US20070134654 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac |
| 06/14/2007 | US20070134352 Topical burn composition |
| 06/14/2007 | US20070134348 for an extracorporeal blood treatment; aqueous substitution infusion fluid comprising electrolytes but excluding magnesium and calcium, and infusion fluid comprising calcium ions and magnesium ions |
| 06/14/2007 | US20070134343 surgical injection of dehydrated particles or a gel or suspension into the joint; mixtures may also include radiocontrast materials, analgesics, antibiotics, proteoglycans, growth factors, and other cells to promote healing and proper joint function |
| 06/14/2007 | US20070134342 Injectable carrier formulations of hyaluronic acid derivatives for delivery of osteogenic proteins |
| 06/14/2007 | US20070134335 Polypeptides with the capacity to entrap drugs and release them in a controlled way |
| 06/14/2007 | US20070134332 Polymer particles for delivery of macromolecules and methods of use |
| 06/14/2007 | US20070134328 Oxymorphone controlled release formulations |
| 06/14/2007 | US20070134303 Protective and therapeutic article |
| 06/14/2007 | US20070134298 Dietary supplement |
| 06/14/2007 | US20070134291 gene therapy; neural epidermal growth factor-like 1(NELL); promoting cartilage formation or repair |
| 06/14/2007 | US20070134285 precipitating an acidic aqueous solution comprising collagen, brushite, a calcium source and a phosphorous source and one or more glycosaminoglycans to form a triple co-precipitate; for synthetic bone, dental materials and regeneration scaffolds |